Takeda Pharmaceutical Company Limited

(PINK:TKPHF)

Latest On Takeda Pharmaceutical Company Limited (TKPHF):

Date/Time Type Description Signal Details
2021-03-30 06:01 ESTDividendA dividend of $90 has been announced on May 13, 2020. It will be paid Nov 30, -0001 with an ex-dividend date of Mar 30, 2021.Neutral
2021-02-06 01:14 ESTFinancialsCompany financials have been released.Neutral
2020-11-26 22:18 ESTFinancialsCompany financials have been released.Neutral
2020-11-08 01:28 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 17:44 ESTFinancialsCompany financials have been released.Neutral
2020-11-03 01:16 ESTFinancialsCompany financials have been released.Neutral
2020-09-26 14:45 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 06:49 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 10:44 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 10:06 ESTFinancialsCompany financials have been released.Neutral
2020-08-03 06:04 ESTEarnings EstimateAn EPS average of $2.20 is estimated for the 2022 year.Buy
2020-08-03 06:04 ESTEarnings EstimateAn EPS average of $0.53 is estimated for the 2021 year.Buy
2020-08-02 02:05 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 18:29 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 06:27 ESTFinancialsCompany financials have been released.Neutral
2020-07-29 22:37 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 14:21 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 19:04 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 10:34 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 18:20 ESTFinancialsCompany financials have been released.Neutral
2020-06-19 14:13 ESTFinancialsCompany financials have been released.Neutral
2020-06-14 06:17 ESTFinancialsCompany financials have been released.Neutral
2020-06-12 07:51 ESTFinancialsCompany financials have been released.Neutral
2020-05-27 06:53 ESTFinancialsCompany financials have been released.Neutral
2020-05-21 02:27 ESTFinancialsCompany financials have been released.Neutral
2020-05-16 02:09 ESTFinancialsCompany financials have been released.Neutral
2020-05-15 21:45 ESTFinancialsCompany financials have been released.Neutral
2020-05-15 06:12 ESTFinancialsCompany financials have been released.Neutral
2020-05-14 14:19 ESTNewsTakeda Pharmaceutical reports FY resultsN/A
2020-05-14 14:19 ESTNewsTakeda Pharmaceutical Company Limited 2019 Q4 - Results - Earnings Call PresentationN/A
2020-05-14 14:18 ESTNewsTakeda Pharmaceutical Company Limited (TKPHF) on Q4 2019 Results - Earnings Call TranscriptN/A
2020-05-06 07:04 ESTFinancialsCompany financials have been released.Neutral
2020-05-01 18:05 ESTFinancialsCompany financials have been released.Neutral
2020-04-20 05:54 ESTFinancialsCompany financials have been released.Neutral
2020-04-14 11:17 ESTNewsTakeda clears FDA hurdle on AlunbrigN/A
2020-04-14 11:15 ESTNewsTakeda gets positive CHMP opinion for subcutaneous vedolizumabN/A
2020-04-14 11:15 ESTNewsTakeda sues Sun Pharma to halt copies of cancer drugN/A
2020-04-14 10:48 ESTNewsEvotec inks deal with and Takeda for gene therapy programsN/A
2020-04-14 10:48 ESTNewsTakeda’s Alunbrig approved as a first-line treatment for ALK+ NSCLC in EuropeN/A
2020-04-07 06:03 ESTFinancialsCompany financials have been released.Neutral
2020-04-03 22:28 ESTFinancialsCompany financials have been released.Neutral
2020-03-30 06:03 ESTDividendA dividend of $90 has been announced on May 14, 2019. It will be paid Jan 1, 1970 with an ex-dividend date of Mar 30, 2020.Neutral
2020-03-25 22:00 ESTFinancialsCompany financials have been released.Neutral
2020-02-28 05:33 ESTFinancialsCompany financials have been released.Neutral
2020-02-27 23:38 ESTFinancialsCompany financials have been released.Neutral
2020-02-22 01:13 ESTFinancialsCompany financials have been released.Neutral
2020-02-21 00:42 ESTFinancialsCompany financials have been released.Neutral
2020-02-18 00:58 ESTFinancialsCompany financials have been released.Neutral
2020-02-13 01:13 ESTFinancialsCompany financials have been released.Neutral
2020-02-08 00:48 ESTFinancialsCompany financials have been released.Neutral

About Takeda Pharmaceutical Company Limited (TKPHF):

Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, and marketing of pharmaceutical products, over-the-counter medicines and quasi-drug consumer products, and other healthcare products. It offers pharmaceutical products in the areas of gastroenterology; oncology; neuroscience; and rare diseases, such as rare metabolic and hematology, and heredity angioedema, as well as plasma-derived therapies and vaccines. The company provides its products under the ENTYVIO, GATTEX/REVESTIVE, ALOFISEL, NATPARA, ADYNOVATE/ADYNOVI, TAKHZYRO, ELAPRASE, VPRIV, GAMMAGARD LIQUID/KIOVIG, HYQVIA, CUVITRU, ALBUMIN/FLEXBUMIN, NINLARO, and ALUNBRIG brands. It operates in Japan, the United States, Europe and Canada, Russia/CIS, Latin America, rest of Asia, the Middle East, Oceania, and Africa. The company has licensing agreements with TESARO, Inc., Denali Therapeutics, and Wave Life Sciences Ltd; collaboration agreements with Rani Therapeutics LLC, Novimmune S.A., AB Biosciences Inc., Sosei Group Corporation, and LogicBio Therapeutics, Inc.; strategic collaboration with Prometheus Biosciences, Inc; a license and research agreement with The University of Texas MD Anderson Cancer Center; a research collaboration agreements with Enzyre BV and Cerevance; a collaboration agreement with Artisan Bio, Inc.; and a multi-target rare disease collaboration with Evox Therapeutics Ltd., as well as licensing agreement with ProThera Biologics Inc. It also has a corporate strategic research alliance with Egle Therapeutics SAS; a strategic partnership with Neurocrine Biosciences, Inc.; Carmine Therapeutics and HemoShear Therapeutics, LLC; and strategic collaboration with KSQ Therapeutics to research, develop, and commercialize immune-based therapies for cancer. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan.

See Advanced Chart

General

  • Name Takeda Pharmaceutical Company Limited
  • Symbol TKPHF
  • Type Common Stock
  • Exchange PINK
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-Specialty & Generic
  • Full Time Employees 47,495
  • Fiscal Year EndMarch
  • Web URLhttp://www.takeda.com
View More

Valuation

  • Trailing PE 23.76
  • Forward PE 10.56
  • Price/Sales (Trailing 12 Mt.) 2.1
  • Price/Book (Most Recent Quarter) 1.45
  • Enterprise Value Revenue 0.03
  • Enterprise Value EBITDA 0.11
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $1.20
  • Next Year EPS Estimate $2.13
  • Profit Margin 6%
  • Return on Assets 1%
  • Return on Equity 4%
  • Earnings Per Share $1.62
  • Revenue Per Share $0
  • Gross Profit 2.2 trillion
  • Quarterly Earnings Growth -2.6%
View More

ESG Rating

  • Rating Date 2019-01-01
  • ESG Score 31.58
  • Environment Score 4.26
  • Social Score 21.31
  • Governance Score 17.52
  • Controversy Level 2
View More

Highlights

  • Market Capitalization 60.67 billion
  • PEG Ratio 0.14
  • Book Value Per Share $25.10
View More

Share Statistics

  • Shares Outstanding 1.58 billion
  • Shares Float 1.56 billion
  • % Held by Insiders 10%
  • % Held by Institutions 38.69%
View More

Technicals

  • Beta 1.11
  • 52 Week High $39.1
  • 52 Week Low $24.17
  • 50 Day Moving Average 35.33
  • 200 Day Moving Average 35.47
View More

Dividends

  • Forward Annual Dividend Rate $1.68
  • Forward Annual Dividend Yield 4.3%
  • Payout Ratio 154%
  • Dividend Date 2010-06-28
  • ExDividend Date 2021-03-30
  • Dividend Per Share $1.64
  • Dividend Yield 0%
View More

Takeda Pharmaceutical Company Limited (TKPHF) Dividend Calendar:

TKPHF's last dividend payment was made to shareholders on June 28, 2010.
Takeda Pharmaceutical Company Limited pays out 154% of its earnings out as a dividend.

Ex-Dividend Date Payment Date Record Date Declared Date Amount
2020-09-292020-12-012020-09-302020-05-13$90
2020-03-302020-06-252020-03-312019-05-14$90
2019-09-272019-12-022019-09-302019-05-14$90
2019-03-292019-06-282019-03-312018-05-14$90
2018-09-282018-12-032018-09-302018-05-14$90
2018-03-292018-06-292018-03-312017-05-10$90
2017-03-302017-06-292017-03-312016-05-10$90
2016-09-292016-12-012016-09-302016-05-10$90
2016-03-302016-06-302016-03-312015-05-15$90
2021-03-300000-00-002021-03-312020-05-13$90
2020-03-302020-03-312019-05-14$90

Takeda Pharmaceutical Company Limited (TKPHF) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.

TKPHF's next estimated earnings release date is June 30, 2021.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312020-12-31$836.75 billion$0.56
2020-09-302020-12-31$N/A$0.57
2020-06-302020-09-30$N/A$0.02$7.96-99.69%
2020-03-312020-06-30$771.7 billion$0.49
2019-12-312020-03-31$7.91 billion$0.01
2019-09-302019-12-31$7.5 billion-$0.19
2019-06-302019-09-30$7.84 billion$0.40
2019-03-312019-06-30$6.44 billion$0.04
2018-12-312019-03-31$4.56 billion-$0.18
2018-09-302018-12-31$3.78 billion$0.44
2018-06-302018-09-30$4.06 billion$0.54$75.90-99.29%
2018-03-312018-06-30$3.79 billion$0.90-$60.20101.49%
2017-12-312018-03-31$4.33 billion-$0.65$29.40-102.21%
2017-09-302017-12-31$3.84 billion$0.77-$2.80127.44%
2017-06-302017-09-30$3.99 billion$0.32$130.30-99.76%
2017-03-312017-06-30$416.21 billion$1.64
2016-12-312017-03-31$465.05 billion-$0.58
2016-09-302016-12-31$416.8 billion$0.45$16.70-97.3%
2016-06-302016-09-30$434.01 billion$0.31$107.95-99.71%
2016-03-312016-06-30$414.12 billion$1.23-$45.60102.71%
2015-12-312016-03-31-$0.38$28.10-101.36%
2015-09-302015-12-31$0.62
2015-06-302015-09-30$0.32
2015-03-312015-06-30$0.25
2014-12-312015-03-31-$2.39$44.05-105.43%
2014-09-302014-12-31$0.19$34.40-99.44%
2014-06-302014-09-30$0.32
2014-03-312014-06-30$0.42$6.00-93.03%
2013-12-312014-03-31-$0.05$0.40-113.35%
2013-09-302013-12-31$0.56
2013-06-302013-09-30$0.46
2013-03-312013-06-30$0.37
2012-12-312013-03-31-$0.10
2012-09-302012-12-31$0.28
2012-06-302012-09-30$0.52
2012-03-312012-06-30$1.39
2011-12-312012-03-31-$0.56
2011-09-302011-12-31$0.41
2011-06-302011-09-30$0.99
2011-03-312011-06-30$1.19
2010-12-312011-03-31$0.49
2010-09-302010-12-31$1.11
2010-06-302010-06-30$0.88
2008-09-302008-09-30$0.78
2008-06-302008-06-30$0.03
2008-03-312008-03-31$0.28
2007-06-302007-06-30$1.26
2007-03-312007-03-31$0.68
2006-12-312006-12-31$1.05
2006-09-302006-09-30$0.34
2006-06-302006-06-30$1.24
2006-03-312006-03-31$0.31
2005-12-312005-12-31$0.96
2005-09-302005-09-30$0.67
2005-06-302005-06-30$1.21
2005-03-312005-03-31$0.34
2004-12-312004-12-31$0.88
2004-09-302004-09-30$0.75
2004-06-302004-06-30$0.92

Takeda Pharmaceutical Company Limited (TKPHF) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Takeda Pharmaceutical Company Limited (TKPHF) Chart:

Takeda Pharmaceutical Company Limited (TKPHF) News:

Below you will find a list of latest news for Takeda Pharmaceutical Company Limited (TKPHF) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Takeda Pharmaceutical Company Limited (TKPHF) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Takeda Pharmaceutical Company Limited (TKPHF) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link